Seronegative autoimmune autonomic ganglionopathy from dual immune checkpoint inhibition in a patient with metastatic melanoma
ConclusionsImmune checkpoint inhibitors can have a wide range of unusual, rare irAEs, including neurotoxicity such as AAG. Clinicians should maintain suspicion for this toxicity so that treatment can be rapidly provided to avoid disability.
Source: Journal for Immunotherapy of Cancer - Category: Cancer & Oncology Source Type: research
More News: Autoimmune Disease | Brain | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Disability | Gastroenterology | Heart | Immunotherapy | Melanoma | Neurology | Reflex Sympathetic Dystrophy | Skin | Skin Cancer | Toxicology | Yervoy